ara-290 vs bpc-157 ARA 290, a Nonerythropoietic Peptide

Naturally occurring compounds like BPC-157 cannot be patented, reducing pharmaceutical industry incentive to fund expensive trials

[DOI] [PMC free article] [PubMed] [Google Scholar] 65.Zimmermann M

"Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review"

Key Benefits Stimulates red blood cell formation: Aids in the prevention and treatment of nutritional and macrocytic anemia

Together, these compounds may provide a synergistic effect, leading to faster restoration, especially useful for complex or chronic conditions needing both tissue repair and anti-inflammatory effects